Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00877331 · ClinicalTrials.gov registry record · NA

Brief Intervention in Primary Care for Problem Drug Use and Abuse

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
868
Enrollment target

NCT00877331: Completed NA study, sponsored by University of Washington.

NCT00877331 is a NA study that has completed, run by University of Washington. The registered enrollment target is 868 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00877331, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
868 participants
Enrollment target

Study Summary

This study will examine the effectiveness of a brief intervention in a primary care setting to reduce drug use or abuse compared to enhanced care as usual.

Primary Outcome

Use of illicit drugs in the past 30 days will be measured by self-reported days of use in the past 30 days and validated by urine toxicological screen.

Interventions

  • BEHAVIORAL Brief intervention using motivational interviewing

Trial Details

FieldValue
Enrollment Target 868 participants
Start Date 2009-04
Est. Completion 2014-09
Phase NA
University of Washington

1,048 total trials

What the finished NCT00877331 record still lists

NCT00877331 is an interventional study that assigns participants to a tested intervention. The registered 868 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (38% lower).

The record links to 0 conditions, and to 1 intervention - of which Brief intervention using motivational interviewing is the first listed.

NCT00877331 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00877331 about?

NCT00877331 is a clinical study titled "Brief Intervention in Primary Care for Problem Drug Use and Abuse". This study will examine the effectiveness of a brief intervention in a primary care setting to reduce drug use or abuse compared to enhanced care as usual.

What is the current status of trial NCT00877331?

This trial is currently completed. It is a NA study. The enrollment target is 868 participants. The study started on 2009-04. Estimated completion is 2014-09.

What interventions are being tested in trial NCT00877331?

The interventions under investigation include: Brief intervention using motivational interviewing (BEHAVIORAL).

Who is sponsoring clinical trial NCT00877331?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00877331's enrollment target sits among peer trials

868 130th of 2000 higher than 1,871 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06077760 · 868 participants · Phase 3

    A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

  • NCT06822790 · 869 participants · Phase 3

    Long-Term Safety and Efficacy of Plozasiran in Adults With Hypertriglyceridemia

  • NCT04933552 · 867 participants

    Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

  • NCT04097145 · 870 participants · NA

    Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00877331, the US trial registry maintained by the National Library of Medicine. NCT00877331 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.